Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.
Skip to main content

Table 4 Vital signs

From: Single-dose intravenous ketamine or intramuscular naltrexone for high-utilization inpatients with alcohol use disorder: pilot trial feasibility and readmission rates

Treatment arm

Baseline SBP (mean mmHg)

Baseline DBP (mean mmHg)

Baseline HR (mean BPM)

40 min SBP (mean mmHg)

40 min DBP (mean mmHg)

40 min HR (mean BPM)

160 min SBP (mean mmHg)

160 min DBP (mean mmHg)

160 min HR (mean mmHg)

KET

125.17

83.83

88.33

137.83**

94.17*

91.00

134.45

85.36

93.27

NTX

126.23

80.85

88.54

127.0

83.08

89.33

   

LA

126.71

86.12

87.76

      
  1. *p < 0.05, **p < 0.01 for H0 = no change from baseline
Back to article page

Addiction Science & Clinical Practice

ISSN: 1940-0640